<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6948816\results\search\country\results.xml">
  <result pre="places : Geographical locations : North America : Central America:" exact="Nicaragua" post=": Computer and Information Sciences: Data Management : Medicine"/>
  <result pre="a population against a new ZIKV outbreak. Data from Managua," exact="Nicaragua" post="showed an imbalance in protective immunity after ZIKV infection"/>
  <result pre="ZIKV caused large-scale epidemics in the populations of Micronesia [3]," exact="French Polynesia" post="[4] and other Pacific islands [1]. ZIKV probably became"/>
  <result pre="then spread rapidly across the continent. In 2015, doctors in" exact="Brazil" post="started reporting clusters of infants born with microcephaly, a"/>
  <result pre="extensively before the 2013 outbreaks. Evidence from seroprevalence studies in" exact="French Polynesia" post="and Fiji found that levels of ZIKV neutralizing antibodies"/>
  <result pre="2013 outbreaks. Evidence from seroprevalence studies in French Polynesia and" exact="Fiji" post="found that levels of ZIKV neutralizing antibodies decrease with"/>
  <result pre="modelling study, based on data from the 2013 epidemic in" exact="French Polynesia," post="estimated that ZIKV outbreaks are unlikely to occur for"/>
  <result pre="some companies have stopped vaccine development [22]. Researchers in Managua," exact="Nicaragua" post="were the first to report the age-stratified seroprevalence of"/>
  <result pre="surveys [23]. The first cases of autochthonous ZIKV infection in" exact="Nicaragua" post="were reported in January, 2016, and an epidemic was"/>
  <result pre="that year. Through case-based surveillance, the public health authorities of" exact="Nicaragua" post="reported a total of 2,795 people with ZIKV detected"/>
  <result pre="adults is in line with findings from seroprevalence studies from" exact="French Polynesia," post="Brazil, and Bolivia [25–27]. In this study, we used"/>
  <result pre="with findings from seroprevalence studies from French Polynesia, Brazil, and" exact="Bolivia" post="[25–27]. In this study, we used published data from"/>
  <result pre="protective immunity to ZIKV infection in the population of Managua," exact="Nicaragua" post="during the period 2017–2097. We assessed: 1) the risk"/>
  <result pre="the consequences of future outbreaks of ZIKV infection in Managua," exact="Nicaragua" post="using a stochastic ABM. The model follows a basic"/>
  <result pre="or immune R). Initial conditions reflected the situation in Managua," exact="Nicaragua" post="in 2017, when there was no documentation of active"/>
  <result pre="computed a rate based on an average birth rate in" exact="Nicaragua" post="of 2.2 births per woman, which was uniformly distributed"/>
  <result pre="reported by Zhang et al. (2017), based on data from" exact="French Polynesia" post="(0.95%, called low risk) and Brazil (2.19% and 4.52%,"/>
  <result pre="on data from French Polynesia (0.95%, called low risk) and" exact="Brazil" post="(2.19% and 4.52%, called intermediate and high risk, respectively)"/>
  <result pre="infection resulting from the reintroduction of the virus in Managua," exact="Nicaragua" post="to reach 1 to 5 cases per 100,000 population"/>
  <result pre="the opposite effects. Human migration from rural areas to Managua," exact="Nicaragua" post="would lead to a sharper decline of protective immunity"/>
  <result pre="modelling study, we show that a new ZIKV outbreak in" exact="Nicaragua" post="would affect proportionally more women in the young reproductive"/>
  <result pre="predictions, uncertainty remains; factors such as the political instability in" exact="Nicaragua" post="could drive migration and influence disease transmission, as we"/>
  <result pre="are similar to the 12–20 years before re-emergence estimated for" exact="French Polynesia" post="[16]. Netto et al. (2017) used an SEIR model"/>
  <result pre="opportunity to be prepared. The next sizeable ZIKV outbreak in" exact="Nicaragua" post="will likely not occur before 2035 but the probability"/>
  <result pre="10.1056/NEJMoa080571519516034 4Cao-LormeauVM, RocheC, TeissierA, RobinE, BerryAL, MalletHP, et al.Zika Virus," exact="French Polynesia," post="South Pacific, 2013. Emerg Infect Dis. 2014;20(6):108510.3201/eid2006.14013824856001 5FariaNR, Do"/>
  <result pre="Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between Zika virus and microcephaly in" exact="French Polynesia," post="2013-15: A retrospective study. Lancet. 2016;387(10033):2125–2132. 10.1016/S0140-6736(16)00651-626993883 11JohanssonMA, Mier-Y-Teran-RomeroL,"/>
  <result pre="declines and neutralization antibodies wane in adults following outbreaks in" exact="French Polynesia" post="and Fiji. bioRxiv. 2019; p. 578211. 16KucharskiAJ, FunkS, EggoRM,"/>
  <result pre="Virus in Island Populations: A Modelling Analysis of the 2013–14" exact="French Polynesia" post="Outbreak. PLoS Negl Trop Dis. 2016;10(5):e000472610.1371/journal.pntd.000472627186984 17AbbinkP, StephensonKE, BarouchDH."/>
  <result pre="TeissierA, HuartM, MerceronS, VanhomwegenJ, RocheC, et al.Ross river virus seroprevalence," exact="French Polynesia," post="2014–2015. Emerg Infect Dis. 2017;23(10):1751–1753. 10.3201/eid2310.17058328930020 26NettoEM, Moreira-SotoA, PedrosoC,"/>
  <result pre="FunkS, KucharskiAJ, et al.High Zika Virus Seroprevalence in Salvador, Northeastern" exact="Brazil" post="Limits the Potential for Further Outbreaks. MBio. 2017;8(6). 10.1128/mBio.01390-1729138300"/>
 </snippets>
</snippetsTree>
